Table 4 Expression profiling of smooth muscle cells (SMCs).
Target tissue | Experimental design | Number of genes affected |
|---|---|---|
Human vascular SMCs [50] | Exposure of cells to iloprost | 83 |
SMCs from coronary artery [63] | Quiescent and invasive SMCs | 47 |
Human aortic SMCs [64] | Exposure to tumour necrosis factor-α | Focus on eotaxin and CCR3 receptor |
Saphenous vein grafts [68] | Comparison with ungrafted veins | 6 |
Human aorta [70] | α -Tocopherol treatment | Focus on connective tissue growth factor |
Arterial SMCs [75] | Butyrate | 58 |